| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Potassium Channels, Tandem Pore Domain | 5 | 2017 | 16 | 1.390 |
Why?
|
| Echocardiography | 12 | 2021 | 911 | 1.310 |
Why?
|
| Sodium | 3 | 2017 | 341 | 1.210 |
Why?
|
| Potassium Channels | 5 | 2011 | 340 | 1.200 |
Why?
|
| Practice Guidelines as Topic | 7 | 2019 | 1034 | 1.070 |
Why?
|
| Potassium Channels, Voltage-Gated | 4 | 2015 | 122 | 1.060 |
Why?
|
| Heart Ventricles | 9 | 2021 | 760 | 0.930 |
Why?
|
| Sumoylation | 3 | 2023 | 18 | 0.920 |
Why?
|
| SUMO-1 Protein | 2 | 2011 | 16 | 0.780 |
Why?
|
| Stroke Volume | 6 | 2021 | 456 | 0.770 |
Why?
|
| Neurons | 5 | 2023 | 1546 | 0.770 |
Why?
|
| Shal Potassium Channels | 2 | 2010 | 5 | 0.710 |
Why?
|
| Ventricular Dysfunction | 2 | 2015 | 28 | 0.660 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2016 | 5 | 0.600 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 187 | 0.600 |
Why?
|
| Heart Valve Diseases | 1 | 2017 | 109 | 0.570 |
Why?
|
| Aortic Valve Stenosis | 4 | 2019 | 131 | 0.550 |
Why?
|
| Aorta | 1 | 2017 | 280 | 0.550 |
Why?
|
| Echocardiography, Doppler | 4 | 2019 | 187 | 0.540 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 165 | 0.520 |
Why?
|
| Algorithms | 5 | 2021 | 1830 | 0.510 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2021 | 516 | 0.500 |
Why?
|
| Aortic Diseases | 1 | 2015 | 100 | 0.490 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 110 | 0.490 |
Why?
|
| Cricetulus | 5 | 2016 | 126 | 0.450 |
Why?
|
| CHO Cells | 5 | 2016 | 187 | 0.450 |
Why?
|
| Potassium | 2 | 2011 | 281 | 0.440 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 275 | 0.420 |
Why?
|
| Ventricular Function, Left | 3 | 2021 | 592 | 0.420 |
Why?
|
| Hypokalemia | 1 | 2011 | 29 | 0.410 |
Why?
|
| Hypoxia | 1 | 2016 | 641 | 0.400 |
Why?
|
| Shab Potassium Channels | 1 | 2011 | 29 | 0.400 |
Why?
|
| Image Enhancement | 2 | 2017 | 563 | 0.390 |
Why?
|
| Aortic Valve | 3 | 2019 | 222 | 0.390 |
Why?
|
| Xenopus laevis | 5 | 2009 | 137 | 0.390 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2010 | 9 | 0.380 |
Why?
|
| Rats | 6 | 2016 | 3990 | 0.370 |
Why?
|
| Societies, Medical | 7 | 2017 | 572 | 0.370 |
Why?
|
| Kv1.3 Potassium Channel | 1 | 2009 | 14 | 0.370 |
Why?
|
| Mitral Valve Stenosis | 1 | 2010 | 37 | 0.360 |
Why?
|
| Scorpion Venoms | 1 | 2009 | 25 | 0.360 |
Why?
|
| Neurotoxins | 1 | 2009 | 49 | 0.360 |
Why?
|
| Potassium Channel Blockers | 1 | 2009 | 64 | 0.360 |
Why?
|
| Humans | 43 | 2021 | 86601 | 0.350 |
Why?
|
| Cell Membrane | 3 | 2010 | 666 | 0.340 |
Why?
|
| Biopolymers | 1 | 2009 | 26 | 0.340 |
Why?
|
| Protein Multimerization | 1 | 2010 | 173 | 0.340 |
Why?
|
| Peptides | 2 | 2009 | 639 | 0.330 |
Why?
|
| Animals | 18 | 2023 | 26581 | 0.330 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 11 | 0.330 |
Why?
|
| Catheterization | 1 | 2010 | 232 | 0.330 |
Why?
|
| Protein Subunits | 1 | 2008 | 122 | 0.320 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 100 | 0.320 |
Why?
|
| Membrane Potentials | 5 | 2015 | 435 | 0.310 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 47 | 0.310 |
Why?
|
| Hippocampus | 1 | 2011 | 442 | 0.310 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 95 | 0.300 |
Why?
|
| Oocytes | 4 | 2009 | 221 | 0.290 |
Why?
|
| Cricetinae | 4 | 2015 | 560 | 0.290 |
Why?
|
| Protein Biosynthesis | 1 | 2008 | 378 | 0.280 |
Why?
|
| Sudden Infant Death | 1 | 2006 | 25 | 0.270 |
Why?
|
| Ion Channel Gating | 2 | 2006 | 324 | 0.270 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 318 | 0.270 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2005 | 12 | 0.260 |
Why?
|
| Muscle Proteins | 1 | 2006 | 132 | 0.260 |
Why?
|
| Sodium Channels | 1 | 2006 | 129 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 663 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 503 | 0.260 |
Why?
|
| Europe | 5 | 2017 | 309 | 0.250 |
Why?
|
| Uterine Hemorrhage | 1 | 2004 | 19 | 0.240 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2016 | 134 | 0.240 |
Why?
|
| COS Cells | 3 | 2010 | 166 | 0.240 |
Why?
|
| Female | 22 | 2021 | 44507 | 0.230 |
Why?
|
| Axon Initial Segment | 1 | 2023 | 2 | 0.230 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2017 | 166 | 0.230 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 3030 | 0.220 |
Why?
|
| Osteoblasts | 2 | 2013 | 95 | 0.210 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 2062 | 0.210 |
Why?
|
| Kidney | 1 | 2008 | 1241 | 0.210 |
Why?
|
| Nursing Staff, Hospital | 1 | 2021 | 42 | 0.200 |
Why?
|
| Models, Molecular | 3 | 2009 | 1286 | 0.190 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 141 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2600 | 0.180 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 87 | 0.180 |
Why?
|
| Ventricular Pressure | 1 | 2019 | 34 | 0.180 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 1990 | 0.180 |
Why?
|
| Male | 16 | 2021 | 40956 | 0.180 |
Why?
|
| Ultrasonography, Interventional | 2 | 2010 | 121 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2818 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 1 | 2019 | 93 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1196 | 0.160 |
Why?
|
| Brain | 1 | 2008 | 2216 | 0.160 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2017 | 25 | 0.150 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 21 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2019 | 290 | 0.150 |
Why?
|
| Ions | 1 | 2017 | 74 | 0.150 |
Why?
|
| Action Potentials | 2 | 2023 | 573 | 0.150 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 49 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2009 | 881 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2705 | 0.140 |
Why?
|
| Gene Deletion | 2 | 2015 | 329 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 2 | 2008 | 396 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 736 | 0.130 |
Why?
|
| Electrophysiology | 2 | 2007 | 401 | 0.130 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2015 | 12 | 0.130 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 12 | 0.130 |
Why?
|
| United States | 7 | 2017 | 6665 | 0.130 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 45 | 0.130 |
Why?
|
| Vaginal Diseases | 1 | 2015 | 27 | 0.130 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2015 | 31 | 0.130 |
Why?
|
| Cerebellum | 1 | 2016 | 247 | 0.130 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 344 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2017 | 394 | 0.130 |
Why?
|
| Menopause | 1 | 2015 | 71 | 0.130 |
Why?
|
| Adult | 8 | 2021 | 25640 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 171 | 0.120 |
Why?
|
| Testosterone | 1 | 2015 | 271 | 0.120 |
Why?
|
| Cardiology | 1 | 2015 | 123 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2015 | 168 | 0.120 |
Why?
|
| Mobile Applications | 1 | 2015 | 63 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2013 | 33 | 0.120 |
Why?
|
| Atrial Flutter | 1 | 2013 | 33 | 0.120 |
Why?
|
| Lung Transplantation | 1 | 2015 | 175 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 373 | 0.110 |
Why?
|
| Graft vs Host Disease | 1 | 2015 | 365 | 0.110 |
Why?
|
| Static Electricity | 2 | 2009 | 89 | 0.110 |
Why?
|
| Medicago truncatula | 1 | 2011 | 3 | 0.110 |
Why?
|
| Rhizobium | 1 | 2011 | 7 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 6501 | 0.100 |
Why?
|
| Autophagy | 1 | 2013 | 149 | 0.100 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2011 | 17 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 379 | 0.100 |
Why?
|
| Ion Transport | 1 | 2011 | 81 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 307 | 0.100 |
Why?
|
| Genome, Plant | 1 | 2011 | 85 | 0.100 |
Why?
|
| Pericardiocentesis | 1 | 2010 | 3 | 0.100 |
Why?
|
| Heart Failure, Systolic | 1 | 2010 | 7 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 291 | 0.100 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 19 | 0.100 |
Why?
|
| Blood Volume | 1 | 2010 | 51 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2013 | 233 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 94 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2011 | 42 | 0.100 |
Why?
|
| Symbiosis | 1 | 2011 | 118 | 0.100 |
Why?
|
| Optical Restriction Mapping | 1 | 2010 | 1 | 0.100 |
Why?
|
| Lysine | 1 | 2011 | 147 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 87 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2010 | 111 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 2011 | 218 | 0.090 |
Why?
|
| Endometrium | 2 | 2015 | 48 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1458 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2011 | 265 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 159 | 0.090 |
Why?
|
| Computer Systems | 1 | 2010 | 79 | 0.090 |
Why?
|
| Electrodes, Implanted | 1 | 2010 | 171 | 0.090 |
Why?
|
| Mice | 5 | 2023 | 11352 | 0.090 |
Why?
|
| Peptide Library | 1 | 2009 | 84 | 0.090 |
Why?
|
| Drug Design | 1 | 2009 | 124 | 0.090 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 10 | 0.090 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 46 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 179 | 0.080 |
Why?
|
| Cell Line | 3 | 2011 | 2468 | 0.080 |
Why?
|
| Mass Screening | 1 | 2013 | 617 | 0.080 |
Why?
|
| Protein Engineering | 1 | 2009 | 140 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2009 | 178 | 0.080 |
Why?
|
| Ligands | 1 | 2009 | 433 | 0.080 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Permeability | 1 | 2008 | 137 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 416 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 989 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 99 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 827 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 878 | 0.080 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 99 | 0.080 |
Why?
|
| Cell Survival | 1 | 2010 | 969 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1014 | 0.080 |
Why?
|
| Muscles | 1 | 2008 | 194 | 0.080 |
Why?
|
| Asparagine | 1 | 2007 | 29 | 0.080 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 485 | 0.080 |
Why?
|
| Molecular Conformation | 1 | 2007 | 96 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2007 | 120 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2021 | 4210 | 0.070 |
Why?
|
| Rabbits | 1 | 2008 | 636 | 0.070 |
Why?
|
| Biophysics | 1 | 2007 | 152 | 0.070 |
Why?
|
| Tryptophan | 1 | 2007 | 90 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 484 | 0.070 |
Why?
|
| Mexiletine | 1 | 2006 | 3 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 896 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 330 | 0.070 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2006 | 31 | 0.070 |
Why?
|
| Diastole | 2 | 2019 | 144 | 0.070 |
Why?
|
| Cytokines | 1 | 2009 | 776 | 0.070 |
Why?
|
| Aged | 6 | 2021 | 18402 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2006 | 58 | 0.070 |
Why?
|
| Lipids | 1 | 2007 | 269 | 0.070 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 34 | 0.070 |
Why?
|
| Protein Binding | 2 | 2009 | 1456 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 55 | 0.070 |
Why?
|
| Genome, Human | 1 | 2010 | 756 | 0.070 |
Why?
|
| Prognosis | 3 | 2019 | 3674 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 493 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 87 | 0.060 |
Why?
|
| Metacarpus | 1 | 2004 | 5 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 408 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2005 | 116 | 0.060 |
Why?
|
| External Fixators | 1 | 2004 | 19 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2009 | 488 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2005 | 217 | 0.060 |
Why?
|
| Environment | 1 | 2006 | 219 | 0.060 |
Why?
|
| Premenopause | 1 | 2004 | 54 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2011 | 918 | 0.060 |
Why?
|
| Menorrhagia | 1 | 2004 | 24 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1195 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2004 | 131 | 0.060 |
Why?
|
| Middle Aged | 5 | 2021 | 25017 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1673 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 3092 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2023 | 80 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1801 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 819 | 0.050 |
Why?
|
| Inservice Training | 1 | 2021 | 38 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 695 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1804 | 0.050 |
Why?
|
| Heart Atria | 2 | 2013 | 250 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 1161 | 0.050 |
Why?
|
| District of Columbia | 1 | 2019 | 20 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2019 | 91 | 0.040 |
Why?
|
| Infant | 1 | 2006 | 3045 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2021 | 228 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2006 | 2767 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2017 | 7988 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 8475 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 298 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 602 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2013 | 1924 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2270 | 0.040 |
Why?
|
| Orchiectomy | 1 | 2015 | 68 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 149 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2016 | 142 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1860 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 268 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 85 | 0.030 |
Why?
|
| Consensus | 1 | 2017 | 335 | 0.030 |
Why?
|
| Endometrial Hyperplasia | 1 | 2015 | 8 | 0.030 |
Why?
|
| Myeloablative Agonists | 1 | 2015 | 34 | 0.030 |
Why?
|
| Vulva | 1 | 2015 | 23 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1576 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2016 | 111 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 34 | 0.030 |
Why?
|
| Dyspareunia | 1 | 2015 | 19 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 136 | 0.030 |
Why?
|
| Unrelated Donors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Siblings | 1 | 2015 | 111 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 116 | 0.030 |
Why?
|
| Placebos | 1 | 2015 | 218 | 0.030 |
Why?
|
| Atrophy | 1 | 2015 | 117 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 429 | 0.030 |
Why?
|
| Postmenopause | 1 | 2015 | 98 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Mutation | 1 | 2005 | 3967 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 304 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 5416 | 0.030 |
Why?
|
| Vagina | 1 | 2015 | 161 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3636 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 996 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 1054 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 999 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 193 | 0.030 |
Why?
|
| Synteny | 1 | 2011 | 25 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2013 | 242 | 0.030 |
Why?
|
| Nitrogen Fixation | 1 | 2011 | 37 | 0.030 |
Why?
|
| Vitis | 1 | 2011 | 19 | 0.030 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2011 | 4 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2011 | 33 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 23 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2011 | 26 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 68 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 55 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 74 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2013 | 223 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2011 | 83 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 80 | 0.020 |
Why?
|
| Venous Pressure | 1 | 2010 | 11 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1538 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 129 | 0.020 |
Why?
|
| Heart Injuries | 1 | 2010 | 16 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 90 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 212 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 2010 | 32 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1849 | 0.020 |
Why?
|
| Hydatidiform Mole | 1 | 2010 | 6 | 0.020 |
Why?
|
| Chest Pain | 1 | 2010 | 42 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 271 | 0.020 |
Why?
|
| Thrombosis | 1 | 2013 | 296 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1823 | 0.020 |
Why?
|
| Dyspnea | 1 | 2010 | 73 | 0.020 |
Why?
|
| Hypotension | 1 | 2010 | 70 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 2010 | 76 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 510 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2013 | 408 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 94 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 782 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1294 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 879 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5974 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1989 | 31 | 0.020 |
Why?
|
| Decision Making | 1 | 2015 | 642 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 1989 | 53 | 0.020 |
Why?
|
| Lung | 1 | 2015 | 1170 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2010 | 464 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1989 | 261 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 1989 | 177 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 265 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2377 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 1284 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 369 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 2356 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1098 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1565 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 2010 | 226 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 539 | 0.020 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 12 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 1078 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2426 | 0.020 |
Why?
|
| Equipment Design | 1 | 2004 | 406 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2010 | 1351 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 2893 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 457 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1620 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 8979 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2010 | 1004 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1989 | 33 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1989 | 102 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1989 | 130 | 0.010 |
Why?
|
| Dogs | 1 | 1989 | 685 | 0.010 |
Why?
|
| Heart Rate | 1 | 1989 | 492 | 0.000 |
Why?
|